Medical Drugs

Diabetes Drug Related Cancer

No longer accepting claims for this case

Medical Study of Incretin Mimetics & Pancreatic Cancer

According to an April 2013 study published in the Journal of the American Medical Association (JAMA), the use of Byetta or Januvia by adults with type 2 diabetes was “associated with significantly increased odds of acute pancreatitis.” Chronic pancreatitis may lead to pancreatic cancer. Unfortunately, pancreatic cancer can be an aggressive form of cancer.  

Following the publication of this study, the FDA released a safety communication regarding the “possible increased risk of pancreatitis and pre-cancerous findings of the pancreas from incretin mimetic drugs for type 2 diabetes.”

Contact a Diabetes Drug Attorney

If you have been diagnosed with pancreatic cancer or lost a loved one to pancreatic cancer after living with type 2 diabetes, you may want to review your medication history for these drugs, please contact medical attorney Kimberly Barone Baden by email or call 1.800.768.4026 to discuss your potential lawsuit.

Please note that we are not reviewing metformin only cases.

Januvia (sitagliptin)

Drug manufacturer Merck allegedly failed to adequately test Januvia and failed to provide adequate risk information to the FDA, healthcare professionals and patients.

Victoza (liraglutide)

The use of Victoza is associated with the risk of pancreatitis, as well as the risk of medullary thyroid cancer. The FDA is requiring Novo Nordisk, the manufacturer of Victoza, to conduct a five-year epidemiological study and to create a medullary thyroid cancer registry to monitor cases related to Victoza use.

Janumet (sitagliptin and metformin)

Janumet, also manufactured by Merck, is a prescription medication in tablet form that has been prescribed for use along with diet and exercise to lower blood sugar in adults with type 2 diabetes. Janumet contains both sitagliptin and metformin.

Byetta (exenatide)

It has been alleged that Byetta make Amylin Pharmaceuticals failed to properly test the drug before bringing it to market and then failed to provide adequate information to the FDA about the drug’s risks. Learn more about the FDA’s warnings about Byettta.

Don't Suffer in Silence

Our firm is built upon advocating for the rights of consumers, workers and families and aggressively seeking justice and accountability for people harmed by wrongdoing and negligence. Motley Rice is committed to obtaining the best possible outcome for clients, investing considerable resources into our clients’ cases.